HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

Бусад хувилбаруудыг харуулах (1)

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Orkin, C, Montoto, S, Shaw, K, Okosun, J, Gandhi, S, Fields, P, Wilson, A, Shanyinde, M, Cwynarski, K, Marcus, R, De Vos, J, Young, A, Tenant-Flowers, M, Johnson, M, Chilton, D, Gribben, J, Bower, M
Формат:	Journal article
Хэвлэсэн:	2012

Ижил төстэй зүйлс

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
-н: Montoto, S, зэрэг
Хэвлэсэн: (2011)

HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
-н: Montoto, S, зэрэг
Хэвлэсэн: (2012)

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
-н: Bhanu Vakkalanka, зэрэг
Хэвлэсэн: (2011-01-01)

The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
-н: Adam F. Binder, зэрэг
Хэвлэсэн: (2017-10-01)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
-н: Diego Villa, зэрэг
Хэвлэсэн: (2018-12-01)

Tissue is the issue-sarcoidosis following ABVD chemotherapy for Hodgkin's lymphoma: a case report
-н: Subbiah Vivek, зэрэг
Хэвлэсэн: (2007-11-01)

S202: CHILDBEARING AMONG CLASSICAL HODGKIN LYMPHOMA SURVIVORS TREATED WITH BEACOPP AND ABVD IN SWEDEN, DENMARK, AND NORWAY
-н: J. P. Entrop, зэрэг
Хэвлэсэн: (2022-06-01)

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
-н: Paolo Strati, зэрэг
Хэвлэсэн: (2019-02-01)

A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
-н: Ryo Yonezawa, зэрэг
Хэвлэсэн: (2023-01-01)

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
-н: Schwenkglenks Matthias, зэрэг
Хэвлэсэн: (2010-08-01)

Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
-н: Camille Cotteret, зэрэг
Хэвлэсэн: (2020-04-01)

Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort studyResearch in context
-н: Marriam Mponda, зэрэг
Хэвлэсэн: (2024-03-01)

Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation
-н: Rebecca J. DeBoer, зэрэг
Хэвлэсэн: (2020-11-01)

Advanced Hodgkin's lymphoma: results in 216 patients treated with ABVD in Brazil Linfoma de Hodgkin em estádio avançado: resultados do tratamento em 216 pacientes tratados com ABVD no Brasil
-н: Luciana Britto, зэрэг
Хэвлэсэн: (2010-01-01)

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
-н: Min Hu, зэрэг
Хэвлэсэн: (2023-08-01)

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
-н: Joshua P. Entrop, зэрэг
Хэвлэсэн: (2022-10-01)

PB2260: FIVE-YEAR SINGLE-CENTER EXPERIENCE IN THE TREATMENT OF ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA WITH ABVD
-н: Vojin Vukovic, зэрэг
Хэвлэсэн: (2023-08-01)

Clinical profile and outcome of classical Hodgkin lymphoma treated with ABVD protocol at Homi Bhabha Cancer Hospital Varanasi
-н: NIKITA SINGH, зэрэг
Хэвлэсэн: (2022-01-01)

A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD
-н: Chakraborty R, зэрэг
Хэвлэсэн: (2015-03-01)

P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
-н: Heidi Mocikova, зэрэг
Хэвлэсэн: (2022-10-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
-н: Arun Seshachalam, зэрэг
Хэвлэсэн: (2019-12-01)

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
-н: Jillian R. Gunther, зэрэг
Хэвлэсэн: (2020-07-01)

Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.
-н: Greaves, P, зэрэг
Хэвлэсэн: (2013)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Хэвлэсэн: (2018-10-01)

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
-н: Marc P. E. André, зэрэг
Хэвлэсэн: (2020-09-01)

Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD
-н: Alessandro Cellini, зэрэг
Хэвлэсэн: (2024-09-01)

Brentuximab vedotin followed by ABVD +/− radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study
-н: Massimo Federico, зэрэг
Хэвлэсэн: (2016-04-01)

Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource‐limited country: An observational study
-н: Tawatchai Suwanban, зэрэг
Хэвлэсэн: (2023-08-01)

P1081: PET-ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH-05 TRIAL
-н: A. Pavlovsky, зэрэг
Хэвлэсэн: (2022-06-01)

Influência do CD 20 na refratariedade do linfoma de Hodgkin clássico ao tratamento inicial com o esquema ABVD, no Ceará, Brasil Influence of CD 20 antigen expression in the refractoriness of classical Hodgkin lymphoma in the first line treatment with ABVD protocol in Ceará state, Brazil
-н: Rogério Pinto Giesta, зэрэг
Хэвлэсэн: (2009-06-01)

FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin’s disease-a useful tool for monitoring pulmonary toxicity and disease activity
-н: T. Buchler, зэрэг
Хэвлэсэн: (2007-11-01)

A comparison of clinical profile and treatment outcome of Hodgkin’s Lymphoma in Tanzania according to HIV status during the HAART era
-н: Mercy M. Mbai, зэрэг
Хэвлэсэн: (2024-07-01)

Pilot study of lung cancer screening for survivors of Hodgkin lymphoma
-н: Rachel Broadbent, зэрэг
Хэвлэсэн: (2023-11-01)

P030 (0143) ONCE-A-CYCLE VS. DAILY G-CSF IN EARLY-UNFAVORABLE STAGES OF HODGKIN LYMPHOMA TREATED WITH BEACOPP ESCALATED FOLLOWED BY ABVD
Хэвлэсэн: (2018-10-01)

P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA
-н: N. L. Fiad, зэрэг
Хэвлэсэн: (2022-06-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
-н: Ercole Brusamolino, зэрэг
Хэвлэсэн: (2012-04-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
-н: Ercole Brusamolino, зэрэг
Хэвлэсэн: (2014-08-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
-н: Ercole Brusamolino, зэрэг
Хэвлэсэн: (2012-01-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
-н: Ercole Brusamolino, зэрэг
Хэвлэсэн: (2014-08-01)

P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADEQUATE SURVIVAL.
-н: Michael Dickinson, зэрэг
Хэвлэсэн: (2023-08-01)